You are here: Industry Insights > acquisition

News List

Quotient Clinical announces second US acquisition: QS Pharma pharmaasia
March 06, 2017
Quotient Clinical announced acquisition of QS Pharma, the contract development and manufacturing organisation from Charles River Laboratories International
Sartorius to Acquire Essen BioScience contractpharma
March 06, 2017
Expands bioanalytics portfolio with cell analysis platform for research and drug discovery
Quotient Clinical expands into USA through acquisition of SeaView Research, the specialist clinical pharmaasia
March 03, 2017
Acquisition combines Quotient and SeaView’s complementary customer portfolios strengthening the early phase clinical experience of the combined business.
Eli Lilly acquires CoLucid Pharmaceuticals for $960m pharmaceutical-technology
March 03, 2017
Eli Lilly and Company has completed its previously announced acquisition of US-based CoLucid Pharmaceuticals for ...
Johnson & Johnson completes acquisition of Abbott Medical Optics worldpharmanews
March 02, 2017
Johnson & Johnson (NYSE: JNJ) has completed the acquisition of Abbott Medical Optics (AMO) a wholly-owned subsidiary of Abbott.
Lilly Completes Acquisition of CoLucid Pharmaceuticals lilly
March 02, 2017
Eli Lilly and Company (NYSE:LLY) today announced the successful completion of its acquisition of CoLucid Pharmaceuticals, Inc. (NASD:CLCD).
Recipharm acquires Kemwell’s pharmaceutical businesses in India for $118.5m pharmaceutical-technology
February 22, 2017
Sweden's Recipharm has completed the previously announced acquisition of Kemwell’s pharmaceutical businesses in Bengaluru, India, in a deal valued at Skr1.05bn ($118.5m).
Takeda completes acquisition of ARIAD Pharmaceuticals biospectrumasia
February 22, 2017
This acquisition will significantly enhances Takeda’s global oncology portfolio
Amygdala acquires Gilead’s candidate for addiction treatment pharmafile.com
February 21, 2017
Amygdala Neurosciences has agreed an acquisition with Gilead’s GS-6637.
Baxalta buy drives huge leap in Shire’s Q4 sales pharmatimes
February 20, 2017
Shire has booked sales of $3.62 billion for the fourth quarter, marking a leap of 123 percent driven by its acquisition of Baxalta last year.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page